Sign Up to like & get
recommendations!
0
Published in 2018 at "Nano letters"
DOI: 10.1021/acs.nanolett.8b03015
Abstract: Bortezomib (BTZ) is a first-in-class boronate proteasome inhibitor used for cancer therapy, but its therapeutic efficacy is usually inhibited by dietary polyphenols due to boronate-catechol complexation. Benefiting from such dynamic covalent chemistry, herein we describe…
read more here.
Keywords:
foe friend;
supramolecular nanomedicines;
friend supramolecular;
consisting natural ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Chemistry"
DOI: 10.3389/fchem.2022.815551
Abstract: Nanomedicines provide distinct clinical advantages over traditional monomolecular therapeutic and diagnostic agents. Supramolecular nanomedicines made from in-situ self-assembling peptides have emerged as a promising strategy in designing and fabricating nanomedicines. In-situ self-assambly (SA) allows the…
read more here.
Keywords:
situ self;
assembling peptides;
self assembling;
supramolecular nanomedicines ... See more keywords